Drug-Induced Modulation of T Lymphocytes as a Potential Mechanism of Susceptibility to Infections in Patients with Multiple Myeloma During Bortezomib Therapy

Bortezomib is effective in the therapy of multiple myeloma (MM), but causes infections that are different from those associated with conventional chemotherapy. It is important to identify the risk factors that facilitate infections associated with bortezomib therapy. In the present report, we sought...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juan, Li, Ying, Huang, Beihui, Zheng, Dong, Chen, Mei, Zhou, Zhenhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289524/
https://www.ncbi.nlm.nih.gov/pubmed/25343940
http://dx.doi.org/10.1007/s12013-014-0224-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289524/
https://www.ncbi.nlm.nih.gov/pubmed/25343940
http://dx.doi.org/10.1007/s12013-014-0224-x

Ejemplares similares